Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,392 public trials 2,847 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Natural Killer Cells in Older Patients With Acute Myeloid Leukemia

NCT00540956

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission

NCT00963521

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hematologic Diseases, +8 more
Locations: Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France

View Trial Details

Completed

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

NCT00771433

Conditions: Agranulocytosis, Breast Cancer, Breast Diseases, +12 more
Locations: Centre Regional Francois Baclesse Caen, France

View Trial Details

Completed

Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

NCT00840684

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hematologic Diseases, +4 more
Locations: Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France

View Trial Details

Completed

G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy

NCT00770172

Conditions: Agranulocytosis, Chemotherapeutic Agent Toxicity, Cytopenia, +6 more
Locations: Centre Regional Francois Baclesse Caen, France

View Trial Details

Completed

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

NCT00049413

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: Hoag Cancer Center at Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

View Trial Details

Completed

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

NCT00002504

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

Bloomington Hospital Bloomington, Indiana, United States

St. Vincent Hospital and Health Care Center Research Department Indianapolis, Indiana, United States

Bergan Mercy Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00482495

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse

NCT00002630

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic Jacksonville Jacksonville, Florida, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00478075

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic - Jacksonville Jacksonville, Florida, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions